Omaha, NENCT07650708Now EnrollingIRB Ready

Dry Eye Syndrome (DES) Clinical Trial in Omaha, NE

Access cutting-edge dry eye syndrome (des) treatment through this clinical trial at a research site in Omaha. Study-provided care at no cost to qualified participants.

Sponsored by Vance Thompson Vision

Quick Self-Assessment

See if you qualify for this Omaha location

Preparing your pre-screening questions…

Expert Care in Omaha

Access dry eye syndrome (des) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related dry eye syndrome (des) treatment provided free

Apply for This Omaha Location

Check if you qualify for this dry eye syndrome (des) clinical trial in Omaha, NE

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Omaha

    Convenient for NE residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Omaha site if eligible
  4. 4Begin participation

About This Dry Eye Syndrome (DES) Study in Omaha

Compare eye dryness following laser-assisted in situ keratomileusis (LASIK) surgery to eye dryness prior to receiving perioperative Miebo in patients with dry eye disease (DED)

Sponsor: Vance Thompson Vision

Who Can Participate

Inclusion Criteria

Be at least 18 years of age at the time of consent, able to provide written voluntary informed consent, willing to follow instructions and participate in all trial assessments and visits
Be a candidate for routine, uncomplicated bilateral LASIK surgery (for spherical equivalent \[≤-8.00D\] myopia or myopic astigmatism correction, not combined with any other procedure; monovision myopic targets are allowed, however the myopic target eye will be the non-study \[fellow\] eye)
No history of refractive surgery including implantable Collamer lens (ICL) or cataract surgery
Total CFS score ≥1 and ≤6 using the National Eye Institute scale at Visit 1 (in at least one eye)
Ocular Surface Disease Index (OSDI) ≥13 and ≤22 at Visit 1

Exclusion Criteria

Have any clinically significant ocular surface slit-lamp findings in the study eye that, in the opinion of the Investigator, could interfere with outcomes of a routine, uncomplicated LASIK surgery, including but not limited to:
History of eye trauma/surgery within the last 6 months that resulted in corneal scarring
DED secondary to scarring, irradiation, alkali burns, cicatricial pemphigoid, or destruction of conjunctival goblet cells, Stevens-Johnson syndrome, active blepharitis, or lid margin inflammation
Abnormal cornea (e.g., keratoconus or corneal epithelial defect, pterygium, or history of herpetic keratitis)
Use of any of the following ocular therapies in the study eye within 30 days prior to Visit 1: topical ocular steroid treatments, prescription dry eye therapy (including nasal spray), or topical intraocular pressure-lowering medications
Use of any eye drops (prescription or over the counter) in the study eye within 24 hours prior to Visit 1
Use of any oral medications known to cause ocular drying (e.g., antihistamines, antidepressants, etc.) on a non-stable regimen within 1 month prior to Visit 1 or is expected to be unstable during the trial
Had a LipiFlow®, intense pulsed light (IPL) therapy, etc. in the study eye within 3 months prior to Visit 1
Had received or removed a permanent punctum plug in the study eye within 1 month (3 months for dissolvable punctum plugs) prior to Visit 1
Have worn soft contact lenses within either 3 days prior to the study or rigid gas-permeable contact lenses for 1 month prior to Visit 1 or any planned wear during the study
Have undergone intraocular surgery or ocular laser surgery in the study eye within 3 months prior to Visit 1
Have ocular allergies that are/expected to be active during the trial period
Have active ocular or systemic infection (bacterial, viral, or fungal), including fever
Have any ocular findings or uncontrolled systemic disease that, in the opinion of the Investigator, will interfere with the trial
Female subjects who are pregnant, nursing, or planning a pregnancy
Female subjects of childbearing potential who are not using an acceptable means of birth control; acceptable methods of contraception include hormonal (oral, implantable, injectable, or transdermal) contraception; mechanical (spermicide in conjunction with a barrier such as a diaphragm or condom) contraception; intrauterine device; or surgical sterilization of partner. For non-sexually active female subjects, abstinence may be regarded as an adequate method of birth control; however, if the subject becomes sexually active during the trial, she must agree to use adequate birth control as defined above for the remainder of the trial.
Have a known allergy and/or sensitivity or lack of desired efficacy in response to the investigational drug
Are currently enrolled in an investigational drug or device study or had used an investigational drug or device within 30 days prior to Visit 1 -

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Omaha?

Yes, this clinical trial (NCT07650708) has an active research site in Omaha, NE that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Dry Eye Syndrome (DES) Treatment Options in Omaha, NE

If you're searching for dry eye syndrome (des) treatment options in Omaha, NE, this clinical trial (NCT07650708) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Omaha research site is actively enrolling participants for this clinical trial. You'll receive care from experienced dry eye syndrome (des) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all dry eye syndrome (des) clinical trials near you to find additional studies recruiting in your area.

More Sjogrens Syndrome Trials in Omaha, NE

See all sjogrens syndrome clinical trials recruiting in Omaha — not just this study.

Browse Sjogrens Syndrome Trials in Omaha →

Browse More Trials by Condition

Sjogrens Syndrome TrialsDry Eye TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Omaha?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Omaha, NE